in this issue
Regions :: Western Europe
Novasep completes expansion of HPAPI capacity in France
May 22, 2014 | Deepti Ramesh
Novasep (Pompey, France), a supplier of services and technologies to the life sciences industry, says that it has completed a €4-million ($5.5 million) expansion of its highly potent active pharmaceutical ingredient (HPAPI) manufacturing capabilities at the company’s facility at Le Mans, France. The plant expansion has been fully qualified and is now being used to scale up validation of a commercial antibody-drug conjugate (ADC) payload, Novasep says. ADCs offer a new treatment method for cancer under which cancer cells are destroyed in a more targeted...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee